首 页   本刊简介  编委会  审稿专家  在线期刊  写作规范  广告合作  联系我们
您现在的位置:首页 => 在线期刊 => 2018年 6期药物性肝损伤 => 专家论坛 =>我国药物性肝损伤流行病学研究现状
我国药物性肝损伤流行病学研究现状
Current status of epidemiological studies on drug-induced liver injury in China
文章发布日期:2018年05月07日  来源:  作者:沈弢,黄昕,王誉雅,等  点击次数:661次  下载次数:137次

调整字体大小:

(此处下载失败可以在在线预览处保存副本或者右键另存为)

【摘要】:药物性肝损伤(DILI)的重要性已越来越多地引起政府医药主管部门、制药公司、临床工作者以及普通公众的重视。了解我国DILI的发生率、分布、常见诱发药物等流行病学特征,有助于DILI的预防、临床诊断和治疗,也有助于政府完善有关法规,降低药物不良反应的发生。现就我国DILI的流行病学现状作一阐述。
【Abstract】:Drug-induced liver injury (DILI) has been taken more and more seriously by governmental authorities, pharmaceutical companies, clinical physicians, and the general public. An understanding of the incidence, and distribution of DILI and related drugs is helpful for the prevention, clinical diagnosis, and treatment of DILI and may also help the government to perfect related laws and regulations and reduce the incidence of adverse drug reactions. This article reviews the epidemiology of DILI in China.
【关键字】:药物性肝损伤; 中草药; 抗结核药; 流行病学
【Key words】:drug-induced liver diseases; drugs, Chinese herbal; antitubercular agents; epidemiology
【引证本文】:
SHEN T, HUANG X, WANG YY, et al. Current status of epidemiological study on drug-induced liver injury in China[J]. J Clin Hepatol, 2018, 34(6): 1152-1155. (in Chinese) 沈弢, 黄昕, 王誉雅, 等. 我国药物性肝损伤流行病学研究现状[J]. 临床肝胆病杂志, 2018, 34(6): 1152-1155.

地址:长春市东民主大街519号《临床肝胆病杂志》编辑部 邮编:130061 电话:0431-88782542/3542
临床肝胆病杂志 版权所有 Copyright © 2009 - 2013 Lcgdbzz.org. All Rights Reserv 吉ICP备10000617号

吉公网安备 22010402000041号